epratuzumab April 12, 2017 epratuzumab Trade Name Lymphocide Orphan Indication Non-Hodgkin's lymphoma USA Market Approval USA USA Designation Date 1998-07-13 00:00:00 Sponsor Immunomedics, Inc.;300 The American Road;Morris Plains, New Jersey, 07950
